IDORSIA LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.9 CHF | +9.07% |
|
-3.55% | -10.12% |
| Apr. 26 | Idorsia Gets EU Medicines Regulator's Positive Opinion for Resistant Hypertension Treatment | MT |
| Apr. 11 | Swiss Market Index Falls as ECB Signals June Rate Cut | MT |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,126 | 3,929 | 4,248 | 3,298 | 2,383 | 339.8 | 339.8 | - |
| Enterprise Value (EV) 1 | 1,775 | 3,769 | 3,828 | 4,290 | 3,367 | 1,423 | 1,462 | 1,671 |
| P/E ratio | -5.23 x | -7.96 x | -8.21 x | -4.94 x | -2.87 x | -0.92 x | -1.09 x | -1.63 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 34.8 x | 164 x | 59 x | 94.2 x | 24.6 x | 2.69 x | 1.5 x | 1.3 x |
| EV / Revenue | 29.1 x | 157 x | 53.2 x | 123 x | 34.7 x | 11.3 x | 6.46 x | 6.41 x |
| EV / EBITDA | -5.05 x | -8.16 x | -9.79 x | -7.21 x | -4.57 x | -3.25 x | -4.63 x | -6.71 x |
| EV / FCF | - | -7.02 x | -10.2 x | -6.87 x | -3.84 x | -3.94 x | -3.17 x | -4.41 x |
| FCF Yield | - | -14.2% | -9.77% | -14.5% | -26% | -25.4% | -31.5% | -22.7% |
| Price to Book | 3.2 x | 22.8 x | 6.24 x | 31.7 x | -3.61 x | -0.38 x | -0.42 x | -0.35 x |
| Nbr of stocks (in thousands) | 131,050 | 131,235 | 166,466 | 176,955 | 177,543 | 178,845 | 178,845 | - |
| Reference price 2 | 16.22 | 29.94 | 25.52 | 18.64 | 13.42 | 1.900 | 1.900 | 1.900 |
| Announcement Date | 2/7/19 | 2/6/20 | 2/4/21 | 2/8/22 | 2/7/23 | - | - | - |
1CHF in Million2CHF
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 61 | 24 | 72 | 35 | 97 | 126.2 | 226.3 | 260.8 |
| EBITDA 1 | -351.5 | -462 | -391 | -595 | -737.2 | -438 | -315.7 | -249.1 |
| EBIT 1 | -371 | -482 | -411 | -613 | -757 | -382.1 | -467.9 | -296.4 |
| Operating Margin | -608.2% | -2,008.33% | -570.83% | -1,751.43% | -780.41% | -302.8% | -206.71% | -113.66% |
| Earnings before Tax (EBT) 1 | -387.8 | -485 | -449 | -634.8 | -820.1 | -475.8 | -504.4 | -353.6 |
| Net income 1 | -386 | -494 | -445 | -635 | -828 | -407.1 | -489 | -346.8 |
| Net margin | -632.79% | -2,058.33% | -618.06% | -1,814.29% | -853.61% | -322.59% | -216.05% | -132.98% |
| EPS 2 | -3.100 | -3.760 | -3.110 | -3.770 | -4.670 | -2.074 | -1.735 | -1.165 |
| Free Cash Flow 1 | - | -536.8 | -373.9 | -624 | -875.7 | -361 | -460.4 | -378.8 |
| FCF margin | - | -2,236.86% | -519.35% | -1,782.86% | -902.81% | -286.04% | -203.43% | -145.25% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 2/7/19 | 2/6/20 | 2/4/21 | 2/8/22 | 2/7/23 | - | - | - |
1CHF in Million2CHF
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q2 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 7 | 13 | 17 | 5 | 5 | 17 | 21 | 54 | 21 | 30 | 80 | 18.1 | 15.43 | 29.8 | 38.1 | 34.59 |
| EBITDA 1 | -126 | - | -118 | -224 | -187.8 | -207 | -189 | -174.3 | -193 | -173 | -37 | -188.9 | - | - | - | - |
| EBIT 1 | -130 | -234 | -123 | -228 | -193 | -212 | -193 | -180 | -198 | -177 | 231 | -164.7 | 30.94 | 177.3 | -93.25 | -88.42 |
| Operating Margin | -1,857.14% | -1,800% | -723.53% | -4,560% | -3,860% | -1,247.06% | -919.05% | -333.33% | -942.86% | -590% | 288.75% | -910.03% | 200.54% | 594.82% | -244.75% | -255.59% |
| Earnings before Tax (EBT) 1 | -139 | - | -139 | -253 | -196 | -222 | -216 | -190.3 | -212 | -192 | 225 | -203.6 | - | - | - | - |
| Net income 1 | -139 | -223 | -140 | -252 | -198 | -222 | -216 | -193 | -212 | -193 | 224 | -204.1 | - | - | - | - |
| Net margin | -1,985.71% | -1,715.38% | -823.53% | -5,040% | -3,960% | -1,305.88% | -1,028.57% | -357.41% | -1,009.52% | -643.33% | 280% | -1,128% | - | - | - | - |
| EPS 2 | -0.8300 | -1.340 | -0.8300 | -1.460 | -1.120 | -1.250 | -1.220 | -1.090 | -1.190 | -1.080 | 0.9600 | -0.9733 | -0.5500 | -0.3000 | -0.2500 | -0.1800 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 7/27/21 | 7/27/21 | 10/26/21 | 2/8/22 | 4/26/22 | 7/26/22 | 10/25/22 | 2/7/23 | 4/25/23 | 7/25/23 | 10/24/23 | - | - | - | - | - |
1CHF in Million2CHF
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 991 | 984 | 1,083 | 1,122 | 1,331 |
| Net Cash position 1 | 351 | 160 | 421 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | -1.666 x | -1.335 x | -2.472 x | -3.553 x | -5.344 x |
| Free Cash Flow 1 | - | -537 | -374 | -624 | -876 | -361 | -460 | -379 |
| ROE (net income / shareholders' equity) | -54.8% | -118% | -103% | -167% | - | - | - | - |
| ROA (Net income/ Total Assets) | -28.6% | - | -32.1% | -39.4% | -65.5% | -57.6% | -58.4% | -34.5% |
| Assets 1 | 1,348 | - | 1,385 | 1,611 | 1,264 | 706.5 | 837.1 | 1,004 |
| Book Value Per Share 2 | 5.070 | 1.310 | 4.090 | 0.5900 | -3.720 | -5.010 | -4.540 | -5.400 |
| Cash Flow per Share 2 | -2.830 | -3.520 | -2.550 | -3.500 | -4.840 | -1.400 | -3.170 | -1.350 |
| Capex 1 | 11.6 | 18.8 | 9.27 | 25.5 | 16.6 | 16.1 | 14 | 22.8 |
| Capex / Sales | 19.04% | 78.34% | 12.87% | 72.93% | 17.13% | 12.76% | 6.16% | 8.72% |
| Announcement Date | 2/7/19 | 2/6/20 | 2/4/21 | 2/8/22 | 2/7/23 | - | - | - |
1CHF in Million2CHF
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
8
Last Close Price
1.9
CHF
Average target price
1.724
CHF
Spread / Average Target
-9.28%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.12% | 371M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
- Stock Market
- Equities
- IDIA Stock
- Financials Idorsia Ltd
